COVID-19: NORMEE, invested by Pegasus Tech Venture: Palm vein authentication
COVID-19:Normie Inc.:
We have developed a biometric authentication product that can be used on smartphones.
US Pegasus Tech Ventures:
Implemented a third-party allotment to a fund managed by Pegasus Tech Ventures in the United States.
We raised a total of 270 million yen.
Palm vein authentication:
Register the biometric information with the smartphone camera (visible light camera).
Service providers do not need to install dedicated authentication equipment.
Contactless authentication of biometric information using smartphones and tablet devices.
http://www.normee.co.jp/news/20200602.html
Smartphone vein authentication, developed by a Japanese startup
It is a unique authentication technology that acquires a vein pattern with an ordinary camera.
11 countries in the world: Obtained patents
Conventionally, a vein authentication service that has realized smartphone-based vein authentication that previously required a dedicated device and infrared light.
The company has patents in 11 countries around the world for this technology.
EE Times Japan
https://eetimes.jp/ee/spv/2006/02/news038.html
NORMEE Limited
raised fund total of 270 million yen from PEGASUS TECH Ventures (Head office:California, CEO Anis Uzzaman, hereinafter refered as “PEGASUS”).
Background of this capital increase is：
that users don’t want to interact with shared touch-based devices,
- such as pin pads,
- touch screens, and
- fingerprint scanners
because of Coronavirus, and Coronavirus is driving the need for contactless biometrics.
Palm Vein Authentication of NORMEE ：
enables users to register their palm vein using their smartphone or tablet without specialized devices, and authenticate their palm vein using a smartphone or tablet at shops without specialized devices.
So the users can use biometrics authentication service by non-contact without infection concern to coronavirus.